Charles River Laboratories International (CRL) Capital Leases (2016 - 2018)
Historic Capital Leases for Charles River Laboratories International (CRL) over the last 9 years, with Q4 2018 value amounting to $29.2 million.
- Charles River Laboratories International's Capital Leases fell 349.83% to $29.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $29.2 million, marking a year-over-year decrease of 349.83%. This contributed to the annual value of $29.2 million for FY2018, which is 349.83% down from last year.
- As of Q4 2018, Charles River Laboratories International's Capital Leases stood at $29.2 million, which was down 349.83% from $30.8 million recorded in Q3 2018.
- In the past 5 years, Charles River Laboratories International's Capital Leases registered a high of $37.4 million during Q2 2015, and its lowest value of $717000.0 during Q1 2014.
- Moreover, its 5-year median value for Capital Leases was $30.3 million (2017), whereas its average is $26.3 million.
- In the last 5 years, Charles River Laboratories International's Capital Leases skyrocketed by 342859.14% in 2015 and then crashed by 1951.87% in 2016.
- Over the past 5 years, Charles River Laboratories International's Capital Leases (Quarter) stood at $1.0 million in 2014, then skyrocketed by 3260.0% to $33.6 million in 2015, then decreased by 11.01% to $29.9 million in 2016, then grew by 1.34% to $30.3 million in 2017, then fell by 3.5% to $29.2 million in 2018.
- Its Capital Leases stands at $29.2 million for Q4 2018, versus $30.8 million for Q3 2018 and $30.6 million for Q2 2018.